Sanofi India Limited (SANOFI.NS) NSE
3,265.00
+2.6(+0.08%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
3,265.00
+2.6(+0.08%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
1225
First IPO Date
July 01, 2002
| Name | Title | Pay | Year Born |
| Rachid Ayari | Chief Financial Officer & Whole Time Director | 18.88M | 1975 |
| Bratin Bag | Senior Director of Ethics & Business Integrity, South Asia | 0 | N/A |
| Deepak Arora | Country Lead, Managing Director & General Manager of Pharma | 0 | N/A |
| Haresh Bachubhai Vala | Company Secretary & Compliance Officer | 0 | N/A |
| Mahadev Gawade | Additional Whole-time Director & Site Director - Goa | 0 | N/A |
| K. Narayanaswamy | Senior Director of Accounting & Taxation | 0 | 1955 |
| Nakul Verma | Senior Director of Public Affairs and Head of Public Affairs & Market Access | 0 | N/A |
| N. Suresh Babu | Sales & Customer Engagement Head - Diabetes and Senior Director of Diabetes | 0 | N/A |
| Sanjay V. Chavan | Head of Country Procurement - India | 0 | 1962 |
| Richa Bakshi | Head of People Excellence | 0 | N/A |
| Sudipta Chakraborty | Head of Legal | 0 | N/A |
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.